Lombard Odier Transatlantic’s Pfizer PFE Stock Holding History

Lombard Odier Transatlantic’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$17K	Hold	527	–	–	0.02%	127
2016 Q2	$18K	Hold	527	–	–	0.02%	112
2016 Q1	$15K	Sell	527 -5,112	-91%	-$146K	0.01%	119
2015 Q4	$173K	Hold	5,639	–	–	0.15%	57
2015 Q3	$168K	Hold	5,639	–	–	0.17%	49
2015 Q2	$179K	Hold	5,639	–	–	0.15%	56
2015 Q1	$186K	Hold	5,639	–	–	0.14%	71
2014 Q4	$166K	Buy	+5,639	New	+$162K	0.15%	65

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Lombard Odier Transatlantic's PFE Position: Q3 2016 in Review

Lombard Odier Transatlantic held its Pfizer (PFE) position steady in Q3 2016 at 527 shares worth $17K. The position accounts for 0.02% of the portfolio, ranked #127.

Lombard Odier Transatlantic first reported a position in PFE in Q4 2014 and has held it in 8 quarters since. The position peaked at $186K in Q1 2015. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Lombard Odier Transatlantic held 527 shares of Pfizer worth $17K as of Q3 2016.
Lombard Odier Transatlantic left its Pfizer share count unchanged in Q3 2016.
Pfizer made up 0.02% of Lombard Odier Transatlantic's portfolio in Q3 2016, its #127 holding.
Lombard Odier Transatlantic first reported a position in Pfizer in Q4 2014 and has held it in 8 quarters since.
Lombard Odier Transatlantic's Pfizer position peaked at $186K in Q1 2015.
1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Lombard Odier Transatlantic's 13F filing for Q3 2016, filed 14 Nov 2016.